A FDA warning about high doses of the cholesterol-lowering drug Simvastatin was not aggressively advertised to patients or physicians after they were pushed to switch from Lipitor to the less-expensive drug by pharmacy-benefit plans, according to physicians familiar with the drug.
The views expressed are not those of TheBostonChannel.com, WCVB or its affiliated companies. By posting your comments you agree to accept our Terms of Use.